Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,393 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Is perioperative brachytherapy effective in carcinoma of the tongue?
Santos M, Guinot JL, Tortajada M, Vendrell JB, López C, La Rosa A, Quiles B, Chust M, Montaner A, Arribas L. Santos M, et al. J Contemp Brachytherapy. 2022 Feb;14(1):23-28. doi: 10.5114/jcb.2022.113425. Epub 2022 Feb 8. J Contemp Brachytherapy. 2022. PMID: 35233231 Free PMC article.
High dose rate brachytherapy in early stage squamous-cell carcinoma of the lip.
Mut A, Guinot JL, Arribas L, Díez-Presa L, Tortajada MI, Santos MÁ, Samper J, Santamaría P, Vendrell JB. Mut A, et al. Acta Otorrinolaringol Esp. 2016 Sep-Oct;67(5):282-7. doi: 10.1016/j.otorri.2015.12.003. Epub 2016 Apr 7. Acta Otorrinolaringol Esp. 2016. PMID: 27063585 Free article. English, Spanish.
Should high-dose-rate brachytherapy boost be used in early nasopharyngeal carcinomas?
Guinot JL, Moya A, Santos MA, Peña M, Quiles B, Sanchez-Relucio JC, La Rosa A, Tortajada MI, Arribas L. Guinot JL, et al. Among authors: santos ma. Rep Pract Oncol Radiother. 2020 Jul-Aug;25(4):479-483. doi: 10.1016/j.rpor.2020.04.001. Epub 2020 May 6. Rep Pract Oncol Radiother. 2020. PMID: 32494223 Free PMC article.
10,393 results
You have reached the last available page of results. Please see the User Guide for more information.